340B Program

The 340B program allows qualifying safety net providers that serve a high proportion of low-income, uninsured, and underinsured patients to purchase outpatient drugs at a discounted price from pharmaceutical manufacturers. GNYHA continues to educate lawmakers on the importance of the 340B program, and will keep members informed on program updates.

14 Items in 340B Program
News
Interim Final Rule Pegs Medicare Drug Payments to Lower Prices Paid Abroad
November 21, 2020
Finance & Insurance Medicare 340B Program
Finance Icon
News
CMS Proposes Additional 340B Drug Cuts, Makes Certain Telehealth Provisions Permanent, and Responds to Allina Ruling
August 6, 2020
Finance & Insurance Medicare 340B Program
Finance Icon
News
Proposed Collection of 340B Acquisition Cost Data Under OMB Review
February 18, 2020
Finance & Insurance Medicare 340B Program
Finance Icon
News
GAO Recommends Increased Oversight of 340B Program
February 18, 2020
Finance & Insurance Medicare 340B Program
Finance Icon
News
GNYHA Opposes Survey of 340B Drug Acquisition Costs
December 16, 2019
Finance & Insurance Medicare 340B Program
Finance Icon
News
CMS Proposes to Collect 340B Acquisition Cost Data
October 2, 2019
Finance & Insurance Medicare 340B Program
Finance Icon
Data
2019 Payment Rates for Drugs Subject to the 340B Cuts
November 30, 2018
Finance & Insurance Medicare 340B Program
Finance Icon
Data
Claim-Level Calculator for Appeals Related to 340B Payment Cuts
April 6, 2018
Finance & Insurance Medicare 340B Program
Finance Icon
News
340B Update: Preserve Your Appeal Rights
April 6, 2018
Finance & Insurance Medicare 340B Program
Finance Icon
News
340B Lawsuit Dismissed on Technical Grounds
December 29, 2017
Finance & Insurance Medicare 340B Program
Finance Icon
News
GNYHA Participates as Amicus in Lawsuit to Halt 340B Cuts
December 4, 2017
Finance & Insurance Medicare 340B Program
Finance Icon
News
Lawsuit, Legislation Filed in Response to Damaging 340B Cut
November 15, 2017
Finance & Insurance Medicare 340B Program
Finance Icon